SCFA can modify immune response to pulmonary inflammation [39] through the activation of G-protein receptors on neutrophils and macrophages, inhibiting histone deacetylase, 3-hydroxy-3-methylglutaryl-coenzyme A reductase and nuclear factor-κB (NF-κB). The gene discussed is HMGCR; the disease is inflammatory response.